)
AnteoTech (ADO) investor relations material
AnteoTech Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business profile
Established in 2000 and listed on the ASX in 2006; a proprietary chemical and advanced-materials platform serves life sciences and next-generation batteries.
Life sciences products serve target markets with ~US$90B in annual sales; operations include laboratories, testing facilities and a pilot plant.
AnteoBind platform
AnteoBind uses proprietary surface chemistry to bind antibodies and other biomolecules to diagnostic surfaces; AnteoBind NXT is designed to improve assay performance and manufacturing efficiency.
Stated product benefits include up to 90% lower antibody requirements, up to 45 times higher signal versus traditional chemistries, coating stability over 12 months, and improved compatibility and specificity.
Applications span lateral flow, CLIA, ELISA and biosensors, including particle conjugation, magnetic bead activation, microplate coating and biomolecule immobilisation on sensor surfaces.
Commercial position
Signed a five-year, US$1.8M take-or-pay supply agreement with Serum Institute of India in mid-2024; distributor arrangements include Cosmo Bio in Japan and KOMA in South Korea.
A paid CLIA development program with a major global life sciences company is in progress; sample evaluations and sales-qualified leads span four diagnostic platforms.
Platform discussions underway: 17 lateral flow, 9 CLIA, 2 ELISA and 3 biosensor organisations; counts may overlap across application categories.
Commercial priorities are to progress evaluations and pursue supply agreements in lateral flow, CLIA and ELISA, while exploring biosensors and next-generation diagnostics.
- Net loss narrowed and total revenue reached $3.13M as commercialization advanced in FY2026.ADO
H2 2026 - Ultranode™ 95 validated for drones, new products launched, and cash reserves rose to A$11.2M.ADO
Q4 2026 TU - Scaling high-silicon battery tech and diagnostics for global growth with strong market momentum.ADO
Investor presentation - Record product evaluations and global partnerships drive growth in life sciences and batteries.ADO
Investor presentation - Cash-rich, debt-free, with major product launches and global partnerships driving growth.ADO
Q3 2026 TU - Revenue up, loss down, first commercial sales and major contract secured; going concern risk flagged.ADO
H2 2024 - Proprietary chemistry and AnteoBind NXT drive diagnostics growth and global expansion.ADO
NWR Virtual Healthcare Conference - High-silicon anode solutions deliver superior cycle life, scalability, and cost efficiency.ADO
Investor presentation - Net loss narrowed 36% to $1.4M, with $3.5M raised to support growth and global expansion.ADO
H1 2026
Next AnteoTech earnings date
Next AnteoTech earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)